Nina Ank
Overview
Explore the profile of Nina Ank including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
1097
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansen F, Porsbo L, Frandsen T, Sari Kaygisiz A, Roer L, Henius A, et al.
Int J Antimicrob Agents
. 2023 May;
62(2):106866.
PMID: 37244424
Objectives: This study aimed to characterise carbapenemase-producing Acinetobacter baumannii (A. baumannii) isolates from Danish patients using whole genome sequencing (WGS). It also compared typing and epidemiological data for further investigation...
2.
Agergaard C, Porsbo L, Sydenham T, Hansen S, Steinke K, Larsen S, et al.
Euro Surveill
. 2023 Mar;
28(9).
PMID: 36862098
From October 2022 through January 2023, nine patients with NDM-5/OXA-48-carbapenemase-producing ST79 were detected in Denmark and subsequently one patient in Iceland. There were no nosocomial links between patients, but they...
3.
Fromberg D, Ank N, Nielsen H
J Infect Prev
. 2022 Aug;
23(5):228-234.
PMID: 36003129
Background: The Department of Infection Control, at our University Hospital conducted contact tracing of COVID-19 positive patients and staff members at all hospitals in the North Denmark Region. Aim: To...
4.
Kjaersgaard M, Leth R, Udupi A, Ank N
Infect Dis (Lond)
. 2019 Aug;
51(10):753-763.
PMID: 31389732
The purpose of this study was to implement an education-based antibiotic stewardship programme at two regional hospitals in Denmark, and thereby reduce consumption of antibiotics in general and cephalosporins and...
5.
Ank N, Kjaersgaard M, Leth R
Dan Med J
. 2018 Jul;
65(7).
PMID: 29961444
Introduction: Our objective was to investigate the know-ledge of "Guidelines on prescribing antibiotics for physicians and others in Denmark" published by the Danish Health Au-thority in 2012, and the usefulness...
6.
Kragelund S, Kjaersgaard M, Jensen-Fangel S, Leth R, Ank N
J Biomed Inform
. 2018 Apr;
81:112-118.
PMID: 29649526
The aim of this study was to develop an audit tool with a built-in database using Research Electronic Data Capture (REDCap®) as part of an antimicrobial stewardship program at a...
7.
Ank N, Sydenham T, Iversen L, Justesen U, Wang M
Int J Antimicrob Agents
. 2015 May;
46(1):117-20.
PMID: 25940770
Here we describe a patient undergoing extensive abdominal surgery and hyperthermic intraperitoneal chemotherapy due to primary adenocarcinoma in the sigmoid colon with peritoneal carcinomatosis. During hospitalisation the patient suffered from...
8.
Iversen M, Ank N, Melchjorsen J, Paludan S
J Virol
. 2010 Feb;
84(9):4579-86.
PMID: 20181703
Interferons (IFNs) are induced as an initial response to viral infection after recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs). Here, we report that different PAMPs induce...
9.
Ank N, Paludan S
Biofactors
. 2009 Mar;
35(1):82-7.
PMID: 19319850
Cytokines are small secreted molecules, which mediate cross-talk between cells involved in the immune response. Interferons (IFN)s, constitute a class of cytokines with antiviral activities, and the type I IFNs...
10.
Ank N, Iversen M, Bartholdy C, Staeheli P, Hartmann R, Jensen U, et al.
J Immunol
. 2008 Feb;
180(4):2474-85.
PMID: 18250457
Type III IFNs (IFN-lambda/IL-28/29) are cytokines with type I IFN-like antiviral activities, which remain poorly characterized. We herein show that most cell types expressed both types I and III IFNs...